Capitalization 7.79B 2.08B 1.78B 1.66B 1.54B 2.88B 188B 3.11B 19.09B 7.51B 89.73B 7.63B 329B P/E ratio 2025 *
25.3x
P/E ratio 2026 * 20.9x
Enterprise value 8.54B 2.28B 1.95B 1.82B 1.69B 3.16B 206B 3.41B 20.92B 8.23B 98.37B 8.37B 360B EV / Sales 2025 *
2.72x
EV / Sales 2026 * 2.48x
Free-Float
22.77%
Yield 2025 *
0.64%
Yield 2026 * 0.88%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.30%
1 week+1.99%
Current month-0.94%
1 month-2.37%
3 months-20.14%
6 months-15.51%
Current year-0.94%
More quotes
1 week 33.02
Extreme 33.02
34.08
1 month 33.02
Extreme 33.02
35.52
Current year 33.02
Extreme 33.02
34.38
1 year 33.02
Extreme 33.02
70.5
3 years 33.02
Extreme 33.02
72.9
5 years 33.02
Extreme 33.02
72.9
10 years 33.02
Extreme 33.02
72.9
More quotes
Manager TitleAgeSince
Chief Executive Officer 62 01/01/2012
Director of Finance/CFO 60 08/12/2020
Director TitleAgeSince
Director/Board Member 73 20/06/2021
Director/Board Member 62 20/06/2021
Chairman 50 01/01/2017
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.24%+1.99%-50.90% - 2.08B
-0.12%-1.05%+19.01%+41.54% 18.43B
-1.01%+4.09%-7.50%-54.83% 15.62B
-0.53%-2.35%+8.43%+67.74% 11.58B
-0.16%-0.45%+33.02%+80.23% 10.21B
-0.08%-5.78%+7.69%+64.24% 10.08B
+2.27%-7.69%-23.08%-40.50% 9.1B
0.00%-3.50%-31.30% - 7.5B
+0.21%-3.28%+37.13%+216.34% 7.61B
+0.22%+3.25%+6.38%-45.11% 5.65B
Average +0.06%-1.50%-0.11%+41.21% 9.79B
Weighted average by Cap. -0.02%-1.62%+5.25%+36.06%
See all sector performances

Financials

2025 *2026 *
Net sales 3.14B 837M 719M 669M 623M 1.16B 75.6B 1.25B 7.69B 3.03B 36.17B 3.08B 133B 3.67B 978M 839M 782M 727M 1.36B 88.31B 1.46B 8.99B 3.53B 42.24B 3.59B 155B
Net income 310M 82.75M 71.01M 66.11M 61.52M 115M 7.47B 124M 760M 299M 3.57B 304M 13.09B 379M 101M 86.67M 80.69M 75.09M 140M 9.12B 151M 928M 365M 4.36B 371M 15.98B
Net Debt 751M 200M 172M 160M 149M 278M 18.07B 299M 1.84B 723M 8.65B 735M 31.68B 1.31B 349M 299M 279M 259M 484M 31.49B 522M 3.2B 1.26B 15.07B 1.28B 55.2B
More financial data * Estimated data
Logo Dr. Soliman Abdel Kader Fakeeh Hospital Company
Dr. Soliman Abdel Kader Fakeeh Hospital Company SCJSC is a Saudi Arabia-based company engaged in operating private hospitals and clinics. It offers its medical services through six units: Specialty Units, which include burn care unit, renal dialysis unit, extended care unit, In vitro fertilization lab, extra corporeal shock wave lithotripsy (ESWL Unit), hyperbaric oxygen unit, bone marrow transplant unit, organ transplantation center, allergy, immunology and respiratory and sleep disorders unit (AIRS Unit); Laboratory Unit, which includes pathology section, hematological diagnosis laboratory, toxicology and drug monitoring laboratory, microbiology laboratory and virology laboratory; Executive Health Program, which is a personalized health Program, offering a range of consultations, investigations and diagnostic procedures; Clinical Department, which includes internal medicine, obstetrics & gynecology, pediatrics, general surgery and anesthesia, among others; Pharmacy, and Radiology.
Employees
2,672
More about the company
Date Price Change Volume
15/01/26 33.80 -0.24% 72,353
14/01/26 33.88 +0.41% 208,437
13/01/26 33.74 +0.84% 636,199
12/01/26 33.46 +0.78% 349,980
11/01/26 33.20 +0.24% 191,262

Delayed Quote Saudi Arabian S.E., January 15, 2026 at 11:34 am

More quotes
Trader
Investor
Global
Quality
ESG MSCI
-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
33.88SAR
Average target price
43.74SAR
Spread / Average Target
+29.10%
Consensus

Quarterly revenue - Rate of surprise